PERSPECTA

News from every angle

← Back to headlines

Moderna Flu Shot Review Agreement Boosts Stock

Moderna's stock surged after the FDA reversed its stance and agreed to review the company's new flu shot.

18 Feb, 16:20 — 18 Feb, 16:20
PostShare
ℹOnly 1 source covers this story

Read at source (1 outlet)

Yahoo6d ago

Moderna stock surges as FDA reverses course, agrees to review new flu shot

Read full article →

Related Stories

Deutsche Bank's Role in Epstein's Financial Transfers Under Scrutiny

8m ago

Euro Area Inflation Drops to 1.7% in January

13m ago

Building Material Prices Continue to Rise in 2026

13m ago

Hungarian Forint Reaches Three-Year High Against Euro

21m ago